Increase efficiencies and productivity by automating core reporting tasks for medical writing.
Automate core regulatory report documents across the CTD pyramid and dramatically accelerate submission timelines.
As we bid farewell to 2023 and reflect on a year filled with groundbreaking developments in generative AI, let’s look back on the significant milestones and events that defined Yseop’s journey in life sciences this year.
In mid-2023, Yseop marked a pivotal milestone with the introduction of Yseop Copilot, an advanced content automation solution designed for the BioPharma industry. Utilizing pre-trained Generative AI (GenAI) models, Yseop Copilot is the most secure digital colleague for scientific writers. The platform brings a substantial boost to writing and reviewing productivity, guaranteeing quality control, and dramatically reducing writing times across hundreds of clinical trials.
Emmanuel Walckenaer, CEO of Yseop, took the spotlight in Fierce Electronics in April, sharing how GenAI is reshaping the drug discovery process. He emphasized the necessity for closed-source solutions in regulated industries and advocated for the effectiveness of a hybrid model.
Recognition from industry leaders
In August we announced our collaboration with GSK, a leading biopharmaceutical company. We helped transform and streamline their clinical document automation for unparalleled efficiency and productivity. By working together, GSK continues to apply technology to improve clinical timelines and enhance efficiencies in Development. This is one of several initiatives that GSK is taking to accelerate regulatory submissions and get medicines and vaccines to patients faster.
